AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.060
+0.010 (0.95%)
Aug 13, 2025, 4:00 PM - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $31.68 million as of August 14, 2025. Its market cap has decreased by -58.34% in one year.
Market Cap
31.68M
Enterprise Value
-31.23M
1-Year Change
-58.34%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $31.68M, a decrease of -88.73%. That is a compound annual growth rate of -47.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 31.68M | -23.16% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |